Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples

被引:65
作者
Bentivegna, Angela [1 ]
Conconi, Donatella [1 ]
Panzeri, Elena [1 ]
Sala, Elena [2 ]
Bovo, Giorgio [3 ]
Vigano, Paolo [4 ]
Brunelli, Silvia [5 ]
Bossi, Mario [1 ]
Tredici, Giovanni [1 ]
Strada, Guido [1 ,4 ]
Dalpra, Leda [1 ,2 ]
机构
[1] Univ Milano Bicocca, Dipartimento Neurosci & Tecnol Biomed, Monza, Italy
[2] Osped San Gerardo, US Genet Med, Monza, Italy
[3] Osped San Gerardo, UO Anat Patolog, Monza, Italy
[4] Osped Bassini ICP, Div Urol, Milan, Italy
[5] Univ Milano Bicocca, Dipartimento Med Sperimentale, Monza, Italy
关键词
TUMOR-INITIATING CELLS; IDENTIFICATION; EVOLUTION; CD133; RISK;
D O I
10.1111/j.1349-7006.2009.01414.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Emerging evidence has suggested that the capability of a tumor to grow and propagate is dependent on a small subset of cells, the cancer stem-like cells (CSCs) or tumor initiating cells. We report on the isolation and biological characterization of putative bladder CSC populations from primary TCCs. Isolated cells were induced to proliferate in stem cell culture conditions (serum-free medium containing mitogenic growth factors). The proliferating cells formed spheroids (urospheres) and their abilities for extensive proliferation and self-renewal were assayed. Their positivity for several stem cell markers (CD133, Oct-3/4, nestin, and cytokeratins) was also assessed by immunofluorescence tests and they could have the potential to differentiate in the presence of serum. In stem cell culture conditions they gradually showed loss of proliferation, adherence to the substrate, and morphological changes, which might reflect their progressive acquisition of differentiative capacity and loss of self-renewal ability. To evaluate if effective cell selection occurred after isolation, conventional cytogenetic studies on fresh chromosome spreads immediately after isolation and after culture were carried out. In addition, a molecular cytogenetic study by UroVysion assay was carried out on paraffin-embedded tissue sections and on fresh and after culture nuclei preparations. The data collected indicated important karyotype changes and a positive selection for hypo- or near-diploid cells, losing the complexity present in fresh tumors. (Cancer Sci 2010; 101: 416-424)
引用
收藏
页码:416 / 424
页数:9
相关论文
共 32 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   Molecular pathways in tumor progression: from discovery to functional understanding [J].
Ali, Muhammad Akhtar ;
Sjoblom, Tobias .
MOLECULAR BIOSYSTEMS, 2009, 5 (09) :902-908
[3]   CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles [J].
Beier, Dagmar ;
Hau, Peter ;
Proescholdt, Martin ;
Lohmeier, Annette ;
Wischhusen, Joerg ;
Oefner, Peter J. ;
Aigner, Ludwig ;
Brawanski, Alexander ;
Bogdahn, Ulrich ;
Beier, Christoph P. .
CANCER RESEARCH, 2007, 67 (09) :4010-4015
[4]   Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings [J].
Bergman, Jonathan ;
Reznichek, Richard C. ;
Rajfer, Jacob .
BJU INTERNATIONAL, 2008, 101 (01) :26-29
[5]   The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells [J].
Bidlingmaier, Scott ;
Zhu, Xiaodong ;
Liu, Bin .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (09) :1025-1032
[6]   Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[7]  
Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19
[8]   Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells [J].
Chan, Keith Syson ;
Espinosa, Inigo ;
Chao, Mark ;
Wong, David ;
Ailles, Laurie ;
Diehn, Max ;
Gill, Harcharan ;
Presti, Joseph, Jr. ;
Chang, Howard Y. ;
van de Rijn, Matt ;
Shortliffe, Linda ;
Weissman, Irving L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :14016-14021
[9]   The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions [J].
Corbeil, D ;
Röper, K ;
Hellwig, A ;
Tavian, M ;
Miraglia, S ;
Watt, SM ;
Simmons, PJ ;
Peault, B ;
Buck, DW ;
Huttner, WB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5512-5520
[10]   The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder [J].
Epstein, JI ;
Amin, MB ;
Reuter, VR ;
Mostofi, FK .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) :1435-1448